• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关性黄斑变性。

Age-Related Macular Degeneration.

机构信息

Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, 645 North Michigan Avenue, Suite 440, Chicago, IL 60611, USA. Electronic address: https://twitter.com/SportsDoc2009.

Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, 645 North Michigan Avenue, Suite 440, Chicago, IL 60611, USA.

出版信息

Med Clin North Am. 2021 May;105(3):473-491. doi: 10.1016/j.mcna.2021.01.003. Epub 2021 Apr 2.

DOI:10.1016/j.mcna.2021.01.003
PMID:33926642
Abstract

Age-related macular degeneration (AMD) is a leading cause of blindness. The main risk factor is advancing age, with the severity of vision loss ranging from mild to severe. There is a 25% risk of early AMD and 8% risk of late AMD in patients over the age of 75, with the number of cases expected to increase because of the aging population. Diagnosis of the disease requires a dilated fundus examination. Physicians should be aware of the symptoms, risk factors, and treatment options for AMD to refer appropriately for ophthalmologic evaluation. Early detection can be helpful to prevent disease progression.

摘要

年龄相关性黄斑变性(AMD)是导致失明的主要原因之一。主要的危险因素是年龄的增长,视力丧失的严重程度从轻度到重度不等。75 岁以上的患者早期 AMD 的风险为 25%,晚期 AMD 的风险为 8%,由于人口老龄化,预计病例数量将会增加。这种疾病的诊断需要进行散瞳眼底检查。医生应该了解 AMD 的症状、危险因素和治疗选择,以便适当地转介进行眼科评估。早期发现有助于防止疾病进展。

相似文献

1
Age-Related Macular Degeneration.年龄相关性黄斑变性。
Med Clin North Am. 2021 May;105(3):473-491. doi: 10.1016/j.mcna.2021.01.003. Epub 2021 Apr 2.
2
Eye Conditions in Older Adults: Age-Related Macular Degeneration.老年人的眼部疾病:年龄相关性黄斑变性
FP Essent. 2016 Jun;445:24-8.
3
[Age-related Macular Degeneration in the Japanese].[日本的年龄相关性黄斑变性]
Nippon Ganka Gakkai Zasshi. 2016 Mar;120(3):163-88; discussion 189.
4
Age-Related Macular Degeneration.年龄相关性黄斑变性
Prim Care. 2015 Sep;42(3):377-91. doi: 10.1016/j.pop.2015.05.009.
5
Age-related macular degeneration in Onitsha, Nigeria.尼日利亚奥尼查的年龄相关性黄斑变性
Niger J Clin Pract. 2011 Jul-Sep;14(3):327-31. doi: 10.4103/1119-3077.86778.
6
Age-Related Macular Degeneration: Epidemiology and Clinical Aspects.年龄相关性黄斑变性:流行病学和临床方面。
Adv Exp Med Biol. 2021;1256:1-31. doi: 10.1007/978-3-030-66014-7_1.
7
Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.玻璃体内曲安奈德治疗年龄相关性黄斑变性的临床证据。
Curr Drug Targets. 2011 Feb;12(2):149-72. doi: 10.2174/138945011794182746.
8
Age-related macular degeneration.年龄相关性黄斑变性。
Pharmacotherapy. 2013 Aug;33(8):838-55. doi: 10.1002/phar.1264. Epub 2013 Apr 11.
9
Age related macular degeneration and visual disability.年龄相关性黄斑变性与视力障碍。
Curr Drug Targets. 2011 Feb;12(2):221-33. doi: 10.2174/138945011794182755.
10
[Progression of treatment and researches in dry age related macular degeneration].[干性年龄相关性黄斑变性的治疗进展与研究]
Zhonghua Yan Ke Za Zhi. 2015 Mar;51(3):236-40.

引用本文的文献

1
C-reactive protein dissociation drives choroidal neovascularization in age-related macular degeneration.C反应蛋白解离驱动年龄相关性黄斑变性中的脉络膜新生血管形成。
Sci Rep. 2025 Aug 26;15(1):31408. doi: 10.1038/s41598-025-16631-z.
2
OBM1701 Alleviates Choroidal Neovascularization in Experimental Animals Via Suppressing the Expression of HIF-1α in Retinal Pigment Epithelial Cells.OBM1701通过抑制视网膜色素上皮细胞中HIF-1α的表达减轻实验动物的脉络膜新生血管形成。
Transl Vis Sci Technol. 2025 Aug 1;14(8):21. doi: 10.1167/tvst.14.8.21.
3
Quantitative characterization of types 1 and 2 macular neovascularization in neovascular age-related macular degeneration with intravitreal conbercept: an analysis utilizing optical coherence tomography angiography.
玻璃体内注射康柏西普治疗新生血管性年龄相关性黄斑变性中1型和2型黄斑新生血管的定量特征:一项利用光学相干断层扫描血管造影的分析
Int J Ophthalmol. 2025 Aug 18;18(8):1490-1497. doi: 10.18240/ijo.2025.08.10. eCollection 2025.
4
From Neurotransmission to Retinal Pathophysiology: Unraveling the Role of GABA Receptors in Retinal Disease Progression.从神经传递到视网膜病理生理学:揭示GABA受体在视网膜疾病进展中的作用
J Neurochem. 2025 Aug;169(8):e70198. doi: 10.1111/jnc.70198.
5
Identification of risk factors for the progression of age-related macular degeneration: a systematic review and meta-analysis of cohort studies.年龄相关性黄斑变性进展的危险因素识别:队列研究的系统评价与荟萃分析
Front Med (Lausanne). 2025 Jul 23;12:1544765. doi: 10.3389/fmed.2025.1544765. eCollection 2025.
6
Immunosenescence: signaling pathways, diseases and therapeutic targets.免疫衰老:信号通路、疾病与治疗靶点。
Signal Transduct Target Ther. 2025 Aug 6;10(1):250. doi: 10.1038/s41392-025-02371-z.
7
Trends and drivers of blindness and vision loss burden attributable to age-related macular degeneration from 1990 to 2021: findings from the Global Burden of Disease Study 2021.1990年至2021年年龄相关性黄斑变性所致失明和视力丧失负担的趋势及驱动因素:全球疾病负担研究2021的结果
BMJ Open. 2025 Jul 22;15(7):e094953. doi: 10.1136/bmjopen-2024-094953.
8
Inorganic nanomaterials as promising therapeutic agents for ocular neovascularization: Progress and perspectives.无机纳米材料作为治疗眼部新生血管的有前景的治疗剂:进展与展望
Mater Today Bio. 2025 Jul 4;33:102051. doi: 10.1016/j.mtbio.2025.102051. eCollection 2025 Aug.
9
Sialylation as a checkpoint for inflammatory and complement-related retinal diseases.唾液酸化作为炎症和补体相关视网膜疾病的一个检查点。
Front Cell Neurosci. 2025 Jun 27;19:1623755. doi: 10.3389/fncel.2025.1623755. eCollection 2025.
10
A comparative study of the effectivity of MSC-based, NP-based and combined therapies in an experimental model of NaIO-induced retinal degeneration.在碘酸钠诱导的视网膜变性实验模型中,基于间充质干细胞、基于纳米颗粒及联合疗法有效性的比较研究。
Sci Rep. 2025 Jul 1;15(1):22281. doi: 10.1038/s41598-025-07727-7.